スケジュール 16 いいね! 0 コメント (0) [ES2TK] Peptide Receptor Radionuclide Therapy of Neuroendocrine Tumors with 177Lu-octreotate: a View to a Kill. ○Lisa Bodei (Chair of EANM Radionuclide Therapy Committee)